Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone (Q74604014)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 October 2001

Language	Label	Description	Also known as
English	Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone	scientific article published on 01 October 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593058%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593058%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593058%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

I Chatzistamou

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593058%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J L Varga

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593058%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

K Groot

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593058%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R Busto

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593058%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

P Armatis

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593058%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

G Halmos

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593058%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593058%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Anti-Cancer Drugs

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593058%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593058%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593058%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

761-768

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593058%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Recent advances in systemic therapy for breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Suppression of tumor growth by growth hormone-releasing hormone antagonist JV-1-36 does not involve the inhibition of autocrine production of insulin-like growth factor II in H-69 small cell lung carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Cancer statistics, 1998.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Hypothalamic hormones and cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Inhibition of growth of the transplantable rat chondrosarcoma by analogs of hypothalamic hormones

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00001813-200110000-00008

Identifiers

10.1097/00001813-200110000-00008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593058%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593058%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74604014&oldid=2105734421"